Makscientific LLC
Burlington, MA
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- SAM.gov registration date
- Physical address
- 151 S Bedford St Ste 104-B, Burlington, MA 01803, USA
- Website
- makscientific.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Northeastern University | U01AA028963 | $255,007 | |
| Northeastern University | U01AA028963 | $255,008 |
Similar vendors
About the company
Makscientific LLC is a for-profit limited liability company registered in SAM.gov since 2004, located in Burlington, Massachusetts. The company appears to be a specialized research and development organization focused on pharmaceutical and medical research, with expertise in developing novel molecular compounds targeting specific receptor systems. Their primary business model centers on scientific research and drug development, particularly in the areas of metabolic disorders, neurological conditions, and substance use disorders.
The company has received multiple federal grant awards from prominent research agencies, including the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Institute on Drug Abuse (NIDA). Their recent grant work includes developing peripherally acting CB1 neutral antagonists for treating diabetic kidney disease, with a $1,145,486 grant focused on designing improved analogs of compound AM6588 to address kidney disease complications. Additionally, Makscientific has been involved in research on cannabis use disorder, developing dual fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL) inhibitors as potential treatment interventions. The company frequently collaborates with Northeastern University through sub-grant awards, working on projects related to CB1 neutral antagonists for alcohol use disorder and compound development. Their research typically involves sophisticated molecular design, synthesis of novel compounds, and comprehensive testing of potential therapeutic agents across various pharmacological domains.
SBA capabilities narrative
We are a small drug discovery entity specializing in areas of pain, addiction, MS, fibrosis, and other diseases
Quick answers
Is Makscientific LLC registered in SAM.gov?
Yes. Makscientific LLC's SAM.gov registration is active through August 7, 2027.
What is Makscientific LLC's CAGE code?
Makscientific LLC's CAGE code is 3YVL5, and its Unique Entity ID (UEI) is J2NHTDAJGK24.
What is Makscientific LLC's most recent federal award?
Makscientific LLC's most recent federal grant award is A CB1 antagonist for treatment of kidney disease - other project information - unit 7 (R44DK139888), from National Institute of Diabetes and Digestive and Kidney Diseases (NIH), on September 1, 2024.
On GovTribe
See Makscientific LLC's full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors